newsfilter
← Latest News
Business Wire·

Sesen Bio Files Definitive Proxy Statement and Mails Letter to Stockholders in Connection with Pending Merger with Carisma Therapeutics

Schedules March 2, 2023, Special Meeting of Stockholders to Vote on Merger Launches www.SesenBioandCarisma.com, Providing Additional Information for Stockholders Sesen Bio, Inc. (NASDAQ:SESN) today announced that it